INTRODUCTION
Good health is a need to all of us, and finding sustainable solutions to health care changes of our changing world cannot wait. That's why DELTA GRAND Pharma is committed to help change millions of lives for better through providing access to safe, effective and advanced products and related health care services to the people who need them. We have a leading portfolio of products that prevent : treat and cure diseases across a broad range of therapeutic areas.
OUR KEY PRINCIPLE
To ensure that we deliver the value our patients and customers need and our shareholders deserve, we focus on continually improving the way we do business, on operating with transparency in everything we do, and on listening to the views of people involved in healthcare decisions.
PRODUCTION LINES
-
Sterile Production Area
This area is established according to CGMP Guidelines to produce:
a- Sterile liquid vilas (2 ml - 100) ml (non-Beta lactam Products) ,Vials Capping (13 mm,20mm or 32 mm)
b- Sterile Eye/Ear Drops:(5ml - 15ml)
c- Ampoules:( 1 ml 10 ml.)
-
Syrup and Suspension Line
This area is established according to CGMP Guidelines to produce:
Syrups and Suspensions for Human (30 ml to 125 ml) -
Solid Dosage Form Area
This area is established according to CGMP Guidelines to produce:
a. Tablets: coated, uncoated, round, oblong, oval, heart-shaped and others. b. Hard Gelatin Capsules: Sizes (2,1,0,00) -
Soft Gelatin Production Area
This area is established according to CGMP Guidelines to produce:
Soft gelatin Capsules with different shapes (round, oblong, oval) and Uses (medicine or dietary supplements).